Christopher John Kenney
CIK 1880129 · View on SEC EDGAR ↗
Insider
First SEC filing: Aug. 25, 2021 · Latest: Aug. 25, 2021
On this page
Insider at
Insider transactions
0 buys (P)
2 sells (S)
Net:
$-244,425
+ 13 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
13 other filings hidden
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 13, 2026 | XENE | S 10b5-1 | 1,410 | $55.22 | $77,860 | 7,069 Direct | -16.63% | Disposed | 15.8% (price as of 2026-08-19) |
| March 10, 2026 | XENE | S 10b5-1 | 2,771 | $60.11 | $166,565 | 4,729 Direct | -36.95% | Disposed | 6.4% (price as of 2026-08-19) |
| March 24, 2023 | XENE | S | 700 | $35.01 | $24,507 | 0 Direct | -100.00% | Disposed | 82.7% (price as of 2026-08-19) |
| Jan. 21, 2022 | XENE | P | 700 | $28.81 | $20,167 | 700 Direct | — | Acquired | 122.0% (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| March 12, 2026 | XENE | Restricted Share Units | Common Shares (3,750) | — | — | 3,750 | Disposed |
| March 9, 2026 | XENE | Performance Share Units | Common Shares (7,500) | — | — | 7,500 | Disposed |
| March 9, 2026 | XENE | Performance Share Units | Common Shares (7,500) | — | — | 7,500 | Acquired |
| Jan. 9, 2026 | XENE | Restricted Share Units | Common Shares (20,000) | $0.00 | — | 20,000 | Acquired |
| Jan. 9, 2026 | XENE | Share Option (Right to Buy) | Common Shares (100,000) | $42.15 | Jan. 8, 2036 | 100,000 | Acquired |
| March 12, 2025 | XENE | Restricted Share Units | Common Shares (15,000) | $0.00 | — | 15,000 | Acquired |
| March 12, 2025 | XENE | Share Option (Right to Buy) | Common Shares (80,000) | $35.48 | March 11, 2035 | 80,000 | Acquired |
| March 11, 2024 | XENE | Stock Option (Right to Buy) | Common Shares (100,000) | $44.37 | March 10, 2034 | 100,000 | Acquired |
| March 10, 2023 | XENE | Stock Option (Right to Buy) | Common Shares (120,000) | $34.18 | March 9, 2033 | 120,000 | Acquired |
| March 10, 2022 | XENE | Stock Option (Right to Buy) | Common Shares (125,000) | $30.01 | March 9, 2032 | 125,000 | Acquired |
| Aug. 23, 2021 | XENE | Stock Option (Right to Buy) | Common Shares (150,000) | $16.64 | Aug. 22, 2031 | 150,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.